174 related articles for article (PubMed ID: 30342234)
1. Beyond endothelial cells: Vascular endothelial growth factors in heart, vascular anomalies and placenta.
Laakkonen JP; Lähteenvuo J; Jauhiainen S; Heikura T; Ylä-Herttuala S
Vascul Pharmacol; 2019 Jan; 112():91-101. PubMed ID: 30342234
[TBL] [Abstract][Full Text] [Related]
2. VEGF Pathways in the Lymphatics of Healthy and Diseased Heart.
Dashkevich A; Hagl C; Beyersdorf F; Nykänen AI; Lemström KB
Microcirculation; 2016 Jan; 23(1):5-14. PubMed ID: 26190445
[TBL] [Abstract][Full Text] [Related]
3. Hereditary vascular anomalies: new insights into their pathogenesis.
Tille JC; Pepper MS
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1578-90. PubMed ID: 15231518
[TBL] [Abstract][Full Text] [Related]
4. Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF Signaling.
Tual-Chalot S; Garcia-Collado M; Redgrave RE; Singh E; Davison B; Park C; Lin H; Luli S; Jin Y; Wang Y; Lawrie A; Jakobsson L; Arthur HM
Circ Res; 2020 Jan; 126(2):243-257. PubMed ID: 31805812
[TBL] [Abstract][Full Text] [Related]
5. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
6. Regulation of placental angiogenesis.
Chen DB; Zheng J
Microcirculation; 2014 Jan; 21(1):15-25. PubMed ID: 23981199
[TBL] [Abstract][Full Text] [Related]
7. Biomolecular markers and involution of hemangiomas.
Frischer JS; Huang J; Serur A; Kadenhe A; Yamashiro DJ; Kandel JJ
J Pediatr Surg; 2004 Mar; 39(3):400-4. PubMed ID: 15017560
[TBL] [Abstract][Full Text] [Related]
8. Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling.
Jin Y; Muhl L; Burmakin M; Wang Y; Duchez AC; Betsholtz C; Arthur HM; Jakobsson L
Nat Cell Biol; 2017 Jun; 19(6):639-652. PubMed ID: 28530660
[TBL] [Abstract][Full Text] [Related]
9. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia.
Sela S; Itin A; Natanson-Yaron S; Greenfield C; Goldman-Wohl D; Yagel S; Keshet E
Circ Res; 2008 Jun; 102(12):1566-74. PubMed ID: 18515749
[TBL] [Abstract][Full Text] [Related]
10. VEGF receptor-2-specific signaling mediated by VEGF-E induces hemangioma-like lesions in normal and in malignant tissue.
Fagiani E; Lorentz P; Bill R; Pavotbawan K; Kopfstein L; Christofori G
Angiogenesis; 2016 Jul; 19(3):339-58. PubMed ID: 27038485
[TBL] [Abstract][Full Text] [Related]
11. Signaling mechanisms in infantile hemangioma.
Boye E; Olsen BR
Curr Opin Hematol; 2009 May; 16(3):202-8. PubMed ID: 19367160
[TBL] [Abstract][Full Text] [Related]
12. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
[TBL] [Abstract][Full Text] [Related]
13. The discovery of placenta growth factor and its biological activity.
De Falco S
Exp Mol Med; 2012 Jan; 44(1):1-9. PubMed ID: 22228176
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-135b-5p Is a Pathologic Biomarker in the Endothelial Cells of Arteriovenous Malformations.
Lee JS; Kim G; Lee JH; Ryu JY; Oh EJ; Kim HM; Kwak S; Hur K; Chung HY
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732107
[TBL] [Abstract][Full Text] [Related]
15. Local serum levels of vascular endothelial growth factor in infantile hemangioma: intriguing mechanism of endothelial growth.
Przewratil P; Sitkiewicz A; Andrzejewska E
Cytokine; 2010 Feb; 49(2):141-7. PubMed ID: 20015661
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions.
Kumazaki K; Nakayama M; Suehara N; Wada Y
Hum Pathol; 2002 Nov; 33(11):1069-77. PubMed ID: 12454810
[TBL] [Abstract][Full Text] [Related]
17. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
18. Expression of Wilms tumor 1 gene distinguishes vascular malformations from proliferative endothelial lesions.
Lawley LP; Cerimele F; Weiss SW; North P; Cohen C; Kozakewich HP; Mulliken JB; Arbiser JL
Arch Dermatol; 2005 Oct; 141(10):1297-300. PubMed ID: 16230568
[TBL] [Abstract][Full Text] [Related]
19. VEGF-A induces angiogenesis, arteriogenesis, lymphangiogenesis, and vascular malformations.
Nagy JA; Vasile E; Feng D; Sundberg C; Brown LF; Manseau EJ; Dvorak AM; Dvorak HF
Cold Spring Harb Symp Quant Biol; 2002; 67():227-37. PubMed ID: 12858545
[No Abstract] [Full Text] [Related]
20. Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer.
Lala PK; Nandi P; Majumder M
Cancer Metastasis Rev; 2018 Sep; 37(2-3):369-384. PubMed ID: 29858743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
